2m 2m 2m 2m 2m 2m 2m
NEUROGENE (NGNE)
NASDAQ
$35.53+$0.05 (+0.13%)
Price as of Sep 11, 2026 7:30 PM EDT- $710.0MMarket Cap
- 86.74%1-Year Change
- BiotechnologyIndustry
NEUROGENE (NGNE)
$35.53+$0.05 (+0.13%)
Earnings Score
Valuation | NGNE | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | NGNE | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 28.36% | ||
12-Month Momentum | 84.16% | ||
3-Month Risk Adjusted Momentum | 98.51% | ||
12-Month Risk Adjusted Momentum | 103.93% |
True Yield
Valuation | NGNE | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | NGNE | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | -1 |